We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
divider
Now Enrolling:
Find out if you are eligible for a clinical trial.
Be sure to ask your doctor questions about your diagnosis and the type of breast cancer you have. Below are some breast cancer subtypes that may help you understand your subtype of cancer.
Knowing which type of breast cancer you have helps doctors decide how to treat it. Different breast cancer subtypes are treated in different ways.
Your participation in clinical trials that focus on tumors with these characteristics may help pave the way to develop more potential treatments for future patients with the same tumors.
ER+/HER2- BREAST CANCER (estrogen receptor positive - sometimes referred to as HR+ or Hormone Receptor positive / human epidermal growth factor receptor 2-positive)
This is a subtype of breast cancer that cancer cells test positive for a receptor proteins that bind to estrogen (ER) and test negative for a protein called human epidermal growth factor receptor 2 (HER2). This subtype of breast cancer is sensitive to treatment with anti-estrogen hormone (endocrine) therapies.
HER2+ BREAST CANCER (human epidermal growth factor receptor 2-positive)
This is a subtype of breast cancer that cancer cells test positive for HER2. This protein promotes the growth of cancer cells. HER2-positive breast cancers tend to be aggressive and are sensitive to HER2-directed therapies.
TRIPLE-NEGATIVE BREAST CANCER (ER-, PR-, HER2-)
This is a subtype of breast cancer that cancer cells test negative for ER, a receptor protein that binds to progesterone (PR) and HER2. This subtype of breast cancer tends to grow and spread faster than other types of breast cancers and are not sensitive to endocrine therapies and HER2-directed therapies.
If you decide you are ready to be a part of a clinical trial, but are unsure where to start, completing the pre-screener questionnaire is the first step. This questionnaire will include questions about your diagnosis that will help find clinical trials that you may match to.
You may be nervous at first, but taking action by completing this questionnaire is the first step in potentially helping others by contributing to breast cancer research. If you do decide to enter a clinical trial, you are free to change your mind about participating at any point during the trial.
Below you will find a list of clinical trials that are sponsored by Bristol Myers Squibb (BMS). Click the “View Trial Details” links below to get more information about each trial. From the top of any trial page, click the purple “Pre-Screen Now” button to answer a few questions and find out if you match to a clinical trial. If you are not a match for a trial sponsored by BMS and you are a match for a trial sponsored by another company, you will be shown those trials to consider.
While a lot of information exists about breast cancer, some of what you have heard may not be accurate. Below is a list of some common myths and facts about breast cancer.
If you are helping your family member or friend through cancer treatment, you are a caregiver. This may mean helping with daily activities such as going to the doctor or making meals. It could also mean coordinating services and care. Or it may be giving emotional and spiritual support.
If you are caring for someone in a clinical trial, there are many things you can do to support them as they participate in the study, such as:.
References:
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information